Advanced glycation end-products in corneas of patients with keratoconus

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 4, 2002, Pages 296-301

  Dawczynski, Jens ^a   Franke, Sibylle ^a   Blum, Marcus ^a   Kasper, Michael ^b   Stein, Günter ^a   Strobel, Jürgen ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BIOSYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATOCONUS; MALE; PATHOGENESIS; PRIORITY JOURNAL; STROMA CELL; TISSUE DISTRIBUTION; VISUAL DISORDER;

ADULT; AGED; CORNEA; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOCONUS; LYSINE; MALE; MIDDLE AGED;

EID: 0036938136     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0445-3     Document Type: Article

References (26)

1. Abalain JH, Dossou H, Colin J, et al (2000) Levels of collagen degradation products (telopeptides) in the tear film of patients with keratoconus. Cornea 19:474-476
2. Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-9
3. Ceriecello A (1999) Hyperglycemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes Nutr Met 12:42-46
4. Collier SA, Madigan MC, Penford PL (2000) Expression of membrane-type 1 matrix metalloprotease (MT1-MMP) and MMP-2 in normal and keratoconus corneas. Curr Eye Res 21:662-668
5. Coyle JT (1984) Keratoconus and eye rubbing. Am J Ophthalmol 97:527-528
6. Franke S, Dawczynski J, Blum M, et al (2000) Levels of advanced glycation end-products (AGEs) in human cataractous lenses. Exp Clin Endocrinol Diabetes 108:A2-A3
7. Hammes HP, Alt A, Niwa T, et al (1999) Differential accumulation of advanced glycated end-products in the course of diabetic retinopathy. Diabetologia 42:728-736
8. Harrison RJ, Klouda PT, Easty DL, et al (1989) Association between keratoconus and atopy. Br J Ophthalmol 73:816-822
9. Helena MC, Barveldt F, Kim WJ, et al (1998) Keratocyte apoptosis following corneal surgery. Invest Ophthalmol Vis Sci 39:276-283
10. Hong SB, Lee KW, Handa JT, et al (2000) Effect of advanced glycation end products on lens epithelial cell in vitro. Biochem Biophys Res Com 275:53-59
11. Ishino Y, Yokoi N, Yasuhara T, et al (2000) Investigation of Corneal Autofluorescence in Diabetic patients. J Jpn Ophthalmol Soc 104:572-576
12. Kaji Y, Usui T, Oshika T, et al (2000) Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 41:362-368
13. Kim WJ, Rabinowitz YS, Meisler DM et al (1999) Keratocyte apoptosis associated with keratoconus. Exp Eye Res 69:475-481
14. Kimura T, Takamatsu J, Ikeda K, et al (1996) Accumulation of advanced glycation end products of the maillard reaction with age in human hippocampal neurons. Neurosci Lett 208:53-56
15. Krachmer JH, Felder RS, Belin MW (1984) Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 28:293-322
16. Macsai MS, Varley GA, Krachmer JH (1990) Development of keratoconus after contact lens wear, Arch Ophthalmol 108:534-538
17. Parker J, Ko WW, Pavlopoulus G et al (1996) Videokeratography of keratoconus in monozygotic twins. J Refract Surg 12:180-183
18. Paul RG, Bailey AJ (1999) The effect of advanced glycation end-products formation upon cell-matrix interaction. Int J Biochem Cell Biol 31:653-660
19. Rabinowitz YS (1998) Major Review: keratoconus. Surv Ophthalmol 42:297-319
20. ε-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34:10872-10878
21. Seiler T, Huhle S, Spoerl E, Kunath H (2000) Manifest diabetes and keratoconus: A retrospective case-control study. Graefe's Arch Clin Exp Ophthalmol 238:822-825
22. Sima AA, Sugimoto K (1999) Experimental diabetic neuropathy: an update. Diabetologia 42:773-788
23. Singh R, Barden A, Mori T, et al (2001) Advanced glycation end-products: a review. Diabetologia 44:129-146
24. Wang Y, Rabinowitz YS, Rotter JI, et al (2000) Genetic epidemiological study of keratoconus: Evidence for major gene determination. Am J Med Genet 93:403-409
25. Wilson SE, Kim WJ (1998) Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci 39:220-226
26. Zhou L, Sawaguchi S, Twining S, et al (1998) Expression of degradative enzymes and protease inhibitors in keratoconus corneas. Invest Ophthalmol Vis Sci 39:1117-1124